Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Agenus Inc
- MiNK Therapeutics, Inc.
Updated Jul 16, 2026
WIINBERG ULF has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | INKT | MiNK Therapeutics, Inc. | A — Grant or award | 1.1K | $12.38 | $14K |
| 2026-06-02 | INKT | MiNK Therapeutics, Inc. | A — Grant or award | 1.3K | $10.90 | $14K |
| 2025-12-03 | INKT | MiNK Therapeutics, Inc. | A — Grant or award | 1.3K | $11.09 | $14K |
| 2025-09-02 | INKT | MiNK Therapeutics, Inc. | A — Grant or award | 1.0K | $13.86 | $14K |
| 2025-06-02 | INKT | MiNK Therapeutics, Inc. | A — Grant or award | 2.0K | $7.17 | $14K |
| 2024-12-03 | INKT | MiNK Therapeutics, Inc. | A — Grant or award | 20.5K | $0.73 | $15K |
WIINBERG ULF is a corporate insider — currently tracked as Insider of MiNK Therapeutics, Inc. (INKT). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live WIINBERG ULF profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.